Herpes Viridae HSV 1 and 2 VZV

Embed Size (px)

Citation preview

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    1/97

    Herpesviridae HSV 1,2 and VZV

    Dr.T.V.Rao MD

    Dr.T.V.Rao MD 1

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    2/97

    Herpesviridae The Herpesviridae are a large family

    of DNA viruses that cause diseases in

    animals, including humans The familyname is derived from the Greek wordherpein ("to creep"), referring to thelatent , re-occurring infections typicalof this group of viruses.Herpesviridae can cause latent or lyticinfections.

    Dr.T.V.Rao MD 2

    http://en.wikipedia.org/wiki/Lytic_cyclehttp://en.wikipedia.org/wiki/Lytic_cycle
  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    3/97

    Herpes Viruses DNA group Most important

    Human Pathogens Wide Host cell range Life Long Infection

    Periodic reactivation Immunocompromised

    Large number ofgenes,

    Some virusessusceptible totreatment. Dr.T.V.Rao MD 3

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    4/97

    Alphaherpesvirinae Herpes simplex virus type 1 HSV-1 Herpes simplex virus type 2 HSV-2

    Varicella-zoster virus VZV Betaherpesvirinae

    cytomegalovirus CMV

    Human herpesvirus type 6 HHV-6 Human herpesvirus type 7 HHV-7

    Gammaherpesvirinae

    Epstein-Barr virus EBV

    CLASSIFICATION(Human pathogens)

    Dr.T.V.Rao MD 4

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    5/97

    Infecting Humans.Herpes Simplex virus 1 and 2Varicella Zoster VirusesCytomegalovirus virusEpstein Barr virusHuman Herpes viruses 6, 7.Kaposi's Sarcoma associated

    Viruses Dr.T.V.Rao MD 5

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    6/97

    Properties of HerpesViruses.

    Spherical in Shape Icosahedral 150

    to 200 nm in size Genome Double

    stranded DNALinear

    Envelope containsGlycoprotein's

    Dr.T.V.Rao MD 6

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    7/97

    Out Standing Characteristics

    Encode many enzymes. Cause Latent Infections. Indefinite persistence. Relation in

    Immunocompromised. Relation to Cancers.

    Dr.T.V.Rao MD 7

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    8/97

    Herpes Virus ReplicationReplicates in Host Cell NucleusForm Cow dry A Type inclusionbodies.More than 50 different types proteins

    in infected cell.Large number of enzymes in DNAsynthesis

    Dr.T.V.Rao MD 8

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    9/97

    Herpes Simplex1 and 2

    Dr.T.V.Rao MD 9

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    10/97

    Herpesviridae Group:Group I

    Family: Herpesviridae Subfamily: Alphaherpesvirinae Genus: Simplexvirus

    Species Herpes simplex

    virus 1 (HWJ-1)Herpes simplex virus 2 (HWJ-2)

    Dr.T.V.Rao MD 10

    http://en.wikipedia.org/wiki/Herpesviridaehttp://en.wikipedia.org/wiki/Herpesviridaehttp://en.wikipedia.org/wiki/Alphaherpesvirinaehttp://en.wikipedia.org/wiki/Alphaherpesvirinaehttp://en.wikipedia.org/wiki/Alphaherpesvirinaehttp://en.wikipedia.org/wiki/Alphaherpesvirinaehttp://en.wikipedia.org/wiki/Herpesviridaehttp://en.wikipedia.org/wiki/Herpesviridae
  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    11/97

    Herpes Simplex Virus

    HSV arespherical inshape

    Ds DNA 35 protein s

    Dr.T.V.Rao MD 11

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    12/97

    Human Herpes Virus 1 and 2

    They are also called Human Herpes Virus 1 and 2 (HHV-1 and HHV-2 ) and areneurotropic and neuroinvasive viruses;

    they enter and hide in the human nervoussystem, accounting for their durability inthe human body. HSV-1 is commonlyassociated with herpes outbreaks of theface known as cold sores or fever blisters,whereas HSV-2 is more often associatedwith genital herpes.

    Dr.T.V.Rao MD 12

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    13/97

    Pathogenesis of HSV 1 &2

    Initialinfection

    siteMigration through Neuron

    replication Sensory ganglia

    latency

    Reactivation is t hrough stress stimulisuch as UV light, fever,

    hormonal changes,surgical trauma to the neuron

    HSV-1: trigeminal gangliaHSV-2: sacral ganglia

    Antibodies do not prevent reactivation

    Dr.T.V.Rao MD 13

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    14/97

    Infections in Humans.( HerpesSimplex 1 and 2 )

    Wide spread in Humans Broad Host Ranges. Replicate in Many types of Cells. Produce cytolytic effects Most Common Diseases. Gingival stomatitis, Kerato conjunctivitis Encephalitis Genital diseases, New Born Infections, Latent Infections in Nerve

    Cells, Recurrence.

    Dr.T.V.Rao MD 14

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    15/97

    HERPES SIMPLEX VIRUS (HSV )

    HSV 1 infect the upper part of thebody

    - mouth and the face HSV 2 infect the lower part of the

    body- genital infections

    There is little cross protection

    Therefore, one can get both theinfections Dr.T.V.Rao MD 15

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    16/97

    Properties of Herpes Simplex Viruses

    Type 1 and 2

    Similar in Organization Restriction Enzyme Differentiates H S V 1 contact with Saliva. H S V 2 Sexual Maternal infection ( Genital Infection

    spreads to New Born ) Replicates in 8-16 hours.

    Dr.T.V.Rao MD 16

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    17/97

    Out characters of Herpesgroup of viruses

    Out standing characters 1 Encode many enzymes Latent infections are common Persist indefinitely in infected hosts. Frequent reactivation in infected hosts Some care cancer causing.

    Dr.T.V.Rao MD 17

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    18/97

    About 75% of the adults show +ve for HSV 1 infection HSV 1 infections include

    -i. Oropharyngeal

    . Children - very painful. due to kissing of elders

    . acute gingivostomatitis

    . problem of feeding

    Dr.T.V.Rao MD 18

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    19/97

    Virus Grows in thefollowing .

    Primary and Continues Cell lines. Monkey and Rabbit Kidney, Human Amnion Syncytial formation and Giant cell

    formations Multiplies in Chorio Allontoic membrane Monoclonal Antibodies differentiates

    Type 1 and 2 types.Dr.T.V.Rao MD 19

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    20/97

    Sources of infection

    - Saliva- Skin lesions

    Oropharyngeallesions

    - Carriers

    Dr.T.V.Rao MD 20

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    21/97

    Transmission Close contact Skin and epithelial contact, Defects in Mucosal membrane Multiples Locally, Enters through cutaneous nerve fibers Intraaxonally to Ganglion

    Centrifugal Migration Recurrent manifestation in Skin and Mucosa.

    Dr.T.V.Rao MD 21

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    22/97

    Dr.T.V.Rao MD 22

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    23/97

    Pathogenesis. Most Common Human Viral Infection Causes cytolytic effect causes the

    necrosis of cells. Infects Skin and Mucous membrane Cowdry type A inclusions are produced Multinucleated Giant cells are

    demonstrated

    Dr.T.V.Rao MD 23

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    24/97

    Pathogenesis

    Entry by skin or mucous membranes

    viral multiplication sensory nerve

    lysis of cells root ganglia

    vesicles latency

    ulcersREACTIVATION

    COLDFEVER

    SURGERYUNKNOWN

    Dr.T.V.Rao MD 24

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    25/97

    Dr.T.V.Rao MD 25

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    26/97

    Predisposition of LatentInfection in

    Ganglion Trigeminal HSV 1 Sacral HSV 2 Immunity. Cell Mediated ( CMI ) Predisposing Factors

    Axonal InjuryPhysical and Emotional stress

    U V light80% Adults harbour Antibodies to HSV

    Dr.T.V.Rao MD 26

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    27/97

    Dr.T.V.Rao MD 27

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    28/97

    Dr.T.V.Rao MD 28

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    29/97

    Dr.T.V.Rao MD 29

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    30/97

    Dr.T.V.Rao MD 30

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    31/97

    Clinical Manifestations Oropharyngeal Disease Buccal Gingival

    Mucosa Incubation 3 to 5 days

    May last for 2-3 weeks Gingvo stomatitis Sub mandibular

    lymphadenopathy

    Present with painful ulcers.

    Dr.T.V.Rao MD 31

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    32/97

    Recurrent Blisters in Herpes simplex 1

    Dr.T.V.Rao MD 32

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    33/97

    Herpes lesions in the oral

    cavity

    Dr.T.V.Rao MD 33

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    34/97

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    35/97

    Herpes simplex 1 infecting eye

    Dr.T.V.Rao MD 35

    H 2 d i

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    36/97

    Herpes 2 producingGenital Lesions

    Dr.T.V.Rao MD 36

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    37/97

    Skin Infections Infect abrasions

    Dentists, ( HerpeticWhitlow) Health careworkers,

    Eczema , Burns

    Dr.T.V.Rao MD 37

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    38/97

    Neonatal Herpes.

    In Uterus At Birth After Birth. Delivery By Caesarean

    SectionReduces the Infection

    Dr.T.V.Rao MD 38

    l f l

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    39/97

    Neonatal Infection Normaldelivery

    Dr.T.V.Rao MD 39

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    40/97

    Other Manifestations. Meningitis, Encephalitis Multi organ Involvement Increased incidence in Immune

    compromised AIDS, Haematological Malignancies.

    Dr.T.V.Rao MD 40

    R t i f ti i HSV

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    41/97

    Recurrent infections in HSV1 and 2

    Dr.T.V.Rao MD 41

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    42/97

    Immunity

    Mothers Ig G protects for 6 months. Primarily Ig M Later Ig g produced.

    Main Participants in Immunity.C M I and Killer Cells and

    Interferon play major role inimmunity

    Dr.T.V.Rao MD 42

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    43/97

    Laboratory Diagnosis

    Microscopy, Antigen Detection DNA detection PCR. Viral Isolation. Serology

    Dr.T.V.Rao MD 43

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    44/97

    Laboratory Diagnosis Specimen: Vesicular fluid- Corneal scrapping1- Direct Virus Demonstration:a) L/M:

    1. Tzanck smear from the base of vesicles,1% aq. soln. of toluidine blue O shows multinucleated giant cells with faceted

    nuclei & homogenously stained ground glasschromatin (Tzanck cells)

    2. Giemsa stained smear intranuclear Cowdry typeA inclusion bodies

    Dr.T.V.Rao MD 44

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    45/97

    B) Direct Immunofluorescence: Cell scrapings from lesions are stained

    with monoclonal antibodies conjugatedwith a fluorescence dye. Viralinclusion bodies appear in UVmicroscope as a bright greenIntranuclear particles

    Dr.T.V.Rao MD 45

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    46/97

    2- Viral Isolation: tissue culture: humandiploid fibroblasts, human amnion, humanembryonic kidney: CPC (syncytiumformation) seen in 24-48 hrs.

    3) Serology : useful in the diagnosis ofprimary infection, Ab (IgM) detection byELISA, NT or CFT.

    Dr.T.V.Rao MD 46

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    47/97

    Childhood infectionscommon

    Second peak at onset ofsexual activity

    Viral shedding persons with recurrences infected but asymptomatic

    persons

    Laboratory diagnosis

    Dr.T.V.Rao MD 47

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    48/97

    Useful genital & eye infections HVZ & HSV in immunocompromised

    patients

    herpes encephalitis Specimens

    aspirate from vesicle

    scraping from base of ulcer serum / CSF for antibody

    Dr.T.V.Rao MD 48

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    49/97

    Microscopy, Tzanck Smear Intranuclear

    Type A InclusionBodies Electron

    Microscopy Fluorescent

    AntibodyDr.T.V.Rao MD 49

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    50/97

    Specimens for Diagnosis.

    Saliva. CSF Vesiclefluid.

    Dr.T.V.Rao MD 50

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    51/97

    Viral Isolation in Chick embryo In Tissue

    CulturesPrimary

    Embryonic

    KidneyHuman

    AmnionDr.T.V.Rao MD 51

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    52/97

    Serology, ELISA Test Neutralization

    Tests Complement

    FixationTests

    Dr.T.V.Rao MD 52

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    53/97

    Chemotherapy Idoxuridine used topically in eye and skin

    infections first successful antiviralagent.

    Acyclovir and vidarabine helps insystemic infections

    Other Drugs Valaciclovir, Famiciclovir, Orally effective Foscarnet.

    Dr.T.V.Rao MD 53

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    54/97

    Epidemiology. World Wide Distribution HSV 1 early in life 6 months to 3 years. 70% to 90% Adults have Antibodies Poor Living Conditions HSV 2 Sexually transmitted. Risk to mother and fetus Abortions < 20 weeks gestation HSV 2 increases predisposition to HIV infection

    Dr.T.V.Rao MD 54

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    55/97

    Varicella Zoster

    Dr.T.V.Rao MD 55

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    56/97

    History of Chickenpox

    The namechicken poxbecause theblisters thatappeared

    seemed like theskin that hasbeen pecked by the chicken..

    Dr.T.V.Rao MD 56

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    57/97

    Herpes Virus

    Dr.T.V.Rao MD 57

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    58/97

    Properties of Virus.

    Like Herpes

    Virus Icosahedrons

    shape dsDNA

    Dr.T.V.Rao MD 58

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    59/97

    Varicella Zoster ( Herpes Virus)DNA Virus

    Varicella -Chickenpox.

    Contagious Disease

    Mainly ChildrenGeneralized Vesicular

    eruptionson Skin and Mucous

    membranesSevere manifestations in

    Adults and Immunecompromised. Dr.T.V.Rao MD 59

    HERPES VARICELLA ZOSTER

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    60/97

    HVZ Causes chicken pox -fever + characteristic rash variable incubation period 14-21 days usually mild in children and more severe in adults complications

    secondary infection - uncommon varicella pneumonia secondary bacterial pneumonia S aureus &

    pneumococci post-infetious encephalitis generalised varicella (in immunocompromised patients) congenital and neonatal varicella

    Dr.T.V.Rao MD 60

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    61/97

    Dr.T.V.Rao MD 61

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    62/97

    Varicella (Chicken Pox) Mild, highly contagious

    disease chieflyaffecting children

    Mode of transmission:

    - airborne droplets anddirect contact fromvaricella patients

    - Vesicular fluid ofZoster patients can bethe source of Varicellain susceptible children

    Dr.T.V.Rao MD 62

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    63/97

    Shingles (Herpes Zoster )

    Rash Limited to Distribution of SingleSensory GanglionIn Adults and immune compromised

    Sporadic

    Dr.T.V.Rao MD 63

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    64/97

    Varicella Zoster Virus (VZV)

    Causes 2 majordiseases

    Varicella (chickenpox): primaryinfection usually inchildhood

    Zoster ( shingles):reactivation of anearlier varicella

    Dr.T.V.Rao MD 64

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    65/97

    Dr.T.V.Rao MD 65

    HERPES VARICELLA ZOSTER

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    66/97

    HVZ Causes chicken pox -fever + characteristic rash variable incubation period 14-21 days usually mild in children and more severe in adults complications

    secondary infection - uncommon varicella pneumonia secondary bacterial pneumonia S aureus &

    pneumococci post-infectious encephalitis generalized varicella (in immunocompromised patients) congenital and neonatal varicella

    Dr.T.V.Rao MD 66

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    67/97

    Herpes Zoster Primary

    Contact -

    Chicken Pox Reactivation

    - Zoster(PartiallyImmune )

    Dr.T.V.Rao MD 67

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    68/97

    Culturing virus Grows in

    Human embryonic TissueProduce inclusion bodiesNo difference in virusIn Chicken pox and

    zoster infectionDr.T.V.Rao MD 68

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    69/97

    Pathogenesis and Pathology Varicella virus enter through

    URT/Conjunctiva.

    Lymph nodes ViremiaLiver and spleen

    Secondary viremiaInfects Mononuclear CellsRash Vesicle formationDr.T.V.Rao MD 69

    Pathogenesis :

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    70/97

    Pathogenesis : VZV infects the mucosa of the upper

    respiratory tract Multiplies in the regional LNs Primary viremia and spread to liver and

    spleen Secondary viremia follows with viral

    spread to the skin

    Typical rash occurs VZV remains latent in the dorsal root

    ganglia for lifeDr.T.V.Rao MD 70

    Clinical Picture:

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    71/97

    Clinical Picture: Incubation period: 10-21 days Symptoms: mild fever & rash Rash: first appears on the trunk, then faceand limbs Flat macules become papules then vesicles Followed by crust formation

    The crust is often shed off and healswithout scarring Cropping is a characteristic feature of

    varicella rash: fresh vesicles appear in crops,

    so that all stages of macules, papules,vesicles & crusts are seen at the same time More severe in adults

    Dr.T.V.Rao MD 71

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    72/97

    Dr.T.V.Rao MD 72

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    73/97

    Herpes Zoster Skin Lesions Inflammation of

    Sensory Nervesand Ganglia Single Ganglion Dorsal root

    Ganglion

    Dr.T.V.Rao MD 73

    Entry of Varicella Zoster

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    74/97

    Entry of Varicella Zostervirus

    Dr.T.V.Rao MD 74

    Skin lesions showing different

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    75/97

    Skin lesions showing differentstages

    Dr.T.V.Rao MD 75

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    76/97

    Clinical Findings. Varicella, Incubation 10-20 days Fever, Malaise

    Rash Trunk

    Face

    Limbs

    Buccal andPharyngeal mucosa Lesions at all stages

    Macules, Papules, Vesicles, Crusts,May last 5 days, Hundreds of eruptions.

    Dr.T.V.Rao MD 76

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    77/97

    Skin lesions of chickenpox

    Dr.T.V.Rao MD 77

    Chicken pox lesions in the

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    78/97

    Chicken pox lesions in thebuccal cavity

    Dr.T.V.Rao MD 78

    Herpes Zoster involving a

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    79/97

    Herpes Zoster involving aNerve segment

    Dr.T.V.Rao MD 79

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    80/97

    Congenital Varicella Syndrome & Neonatal

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    81/97

    Congenital Varicella Syndrome & NeonatalVaricella

    Primary maternal infection during the 1 st trimester may lead to congenitalvaricella syndrome ( serious & fatal): skinlesions, hypoplasia of limbs, chorioretinitis &

    CNS defects Primary maternal infection near the timeof birth can lead to widely disseminatedinfection in the new born with mortalityrate of 35%

    If rash began a week or more before delivery,maternal Abs transferred via placenta baby getsthe infection but escapes clinical disease

    Dr.T.V.Rao MD 81

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    82/97

    Immune compromised HIV / AIDS Malignancies.

    Organtransplantations Corticosteroid

    usage Leukaemia's .

    Dr.T.V.Rao MD 82

    HERPES VARICELLA ZOSTER

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    83/97

    HVZ Causes chicken pox -fever + characteristic rash variable incubation period 14-21 days usually mild in children and more severe in adults complications

    secondary infection - uncommon varicella pneumonia secondary bacterial pneumonia S aureus &

    pneumococci post-infectious encephalitis generalized varicella (in immunocompromised patients) congenital and neonatal varicella

    Dr.T.V.Rao MD 83

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    84/97

    Pain and hyperaesthesia

    Dr.T.V.Rao MD 84

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    85/97

    Pain and hyperaesthesia

    Dr.T.V.Rao MD 85

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    86/97

    Pain and hyperaesthesia

    Dr.T.V.Rao MD 86

    HERPES ZOSTER

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    87/97

    Reactivation of HVZ

    dermatomal distribution may recur can disseminate in immunocompromised patients complications

    post herpetic pain ophthalmic zoster -corneal scarring and loss of vision

    DIAGNOSIS

    CLINICALEM of vesicle fluid

    SEROLOGY

    IgM detectionDr.T.V.Rao MD 87

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    88/97

    Zoster.

    Associated with Immunecompromised.

    Manifest with severe pain Vesicles on trunk , head, neck

    Trigeminal Neuralgia

    Dr.T.V.Rao MD 88

    ( hi l )

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    89/97

    Zoster (shingles)

    Sporadic disease inadults orimmunocompromisedpatients

    Results fromreactivation of latentVZV

    Rash similar tovaricella but limited to

    a nerve distribution tothe skin innervated bya dorsal root ganglion(dermatom)

    Dr.T.V.Rao MD 89

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    90/97

    Pain and hyperaesthesia

    Dr.T.V.Rao MD 90

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    91/97

    Other Complications.

    Encephalitis, Mother to Child

    transmission Varicella Pneumonia. Fatal Complications .

    Dr.T.V.Rao MD 91

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    92/97

    Laboratory Diagnosis. Smears --Scrapings from Lesions

    Demonstration of Multi nucleated giant cellsTzanck smears

    DNA DemonstrationCell cultures,Fluorescent antibodyELISA PCR

    Dr.T.V.Rao MD 92

    Epidemiology

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    93/97

    Communicable Disease World wide prevalence

    Common in < 10 year olds. Zoster in Adults

    Droplet spread

    Dr.T.V.Rao MD 93

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    94/97

    Treatment Specific treatment is indicated mainly

    in Immunodeficient and elderlysubjects and also in complicated withVaricella pneumonia,encephalitis,anddisseminated zoster

    Acyclovir and Famiciclovir.

    Dr.T.V.Rao MD 94

    Prevention of Chickenpox

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    95/97

    Susceptible populationchildren

    adults living in close proximity

    Do nothing

    Immunizelive attenuated

    vaccine

    Protect if contact with patient with chickenpoxand at risk of severe diseaseZoster Immune Globulin (ZIG)Dr.T.V.Rao MD 95

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    96/97

    Vaccine available A live modified Varicella virus

    lyophilised vaccine which can bestored at low temp is availablefor protection

    Children 1 -12 years given single

    dose. >12 years 2 doses 2 -6 weeks

    apart High titre serum from

    convalescing from herpes zoster

    protect Immunocompromisedchildren.

    But not useful for treatment

    Dr.T.V.Rao MD 96

  • 8/6/2019 Herpes Viridae HSV 1 and 2 VZV

    97/97

    Programme created by Dr.T.V.Rao MD forMedical and Paramedical Students in the

    Developing World

    Email

    [email protected]